Regulations.gov document
Letter from FDA CDER to U.S. Patent and Trademark Office
Other · FDA-2020-E-2120 · posted Jun 30, 2022
Key facts
| Document ID | FDA-2020-E-2120-0005 |
|---|---|
| Title | Letter from FDA CDER to U.S. Patent and Trademark Office |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2020-E-2120 |
| Posted | Jun 30, 2022 |
| Comment period opens | Jun 30, 2022 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: